AGPA Webinar: Innovative Income Streams for GP

 

Webinar

Tuesday 12 October 2021, 8:00pm AEDT

7:00 pm Queensland, 7:30 pm SA, 5:00 pm WA

AGPA Webinar
Innovative Income Streams for GP

Speakers:
Dr Maria Boulton, Dr Bernard Shiu, Dr Jared Dart

General Practices are usually small businesses which need to be sustainable if they are going to continue to provide the foundation for primary health care in Australia.
General Practice incomes have been under pressure for many years with MBS payments frozen under successive governments and are now significantly lower than they would otherwise have been. This has impacted both bulk billing and mixed billing practices. At the same time other “traditional” sources of alternate income such as rental space for pathology collection centres also been under pressure.
The pandemic has forced Practices to find new ways to operate including the move to telehealth and the subsequent pressure to move this into video consultation.  These changes have brought increased costs without necessarily improving revenue.

This webinar will discuss options and ideas for extending income sources for General Practice. The speakers are all Practice Principals whose businesses are under the same pressures as other General Practices in Australia. They have developed new and innovative sources of income while maintaining the high quality of Primary Care that Australians expect.

Bookings via TryBooking

https://www.trybooking.com/BUGJQ

Places will be limited, preference will be given to AGPA members.

For further information contact the AGPA Secretariat

Download flyer here

20.3 M Vaccine Doses Delivered

 

At 2 September 20, 329 483 doses of COVID-19 Vaccine had been delivered.

10,649,670 had been delivered by General Practice – from 5,347 participating Practices

The full program summary is here

 

COVID Update Briefs

These are some  updates to the vaccination program that we have found over the last week.  If you need more information please contact the AGPA Secretariat.

  • On 19 August 2021, the TGA approved a name change for the  COVID-19 Vaccine AstraZeneca to VAXZEVRIA.
    The name is now consistent with that used overseas, including in the European Union and Canada.
    This is expected to clarify that the vaccine produced by CSL and Seqirus in Melbourne is the same as that produced internationally, and will help facilitate international recognition for Australians who have been vaccinated with the AstraZeneca vaccine.
  • Pfizer rollout – general practices who have expressed an interest in administering the Pfizer vaccine are expected be transitioned to Pfizer over a four-week period in September/October.
    •  All practices have received the same dose allocation.
    • Start dates and allocation are based on available vaccine supply.
  • ATAGI
    •  ATAGI  has recommended a shorter interval of 4 to 8 weeks between the first and second doses of COVID-19 Vaccine AstraZeneca (Vaxzevria) in an outbreak setting (versus the routine 12-week interval that provides optimal longer-term protection) so that maximal protection against COVID-19 can be achieved earlier.
    • ATAGI recommended strategies  includes increasing the interval between first and second doses of Pfizer (Comirnaty) from 3 weeks to 6 weeks, to facilitate earlier access to first doses in areas of greatest risk of COVID-19..
    • The ATAGI statement of 2 August is here

 

PCIG Notes 25 August 2021

Department of Health – Primary Health Care COVID-19 Response Teleconference 25 August  2021 – Meeting notes from Dr Maria Boulton

The Primary Care Implementation Group (PCIG) is an online meeting that includes most primary healthcare peak bodies. It is convened weekly by the Department of Health as part of the COVID-19 response. Dr Maria Boulton attends on behalf of the AGPA. Continue reading “PCIG Notes 25 August 2021”

Questionnaire on Psoriasis

 

Questionnaire on Psoriasis – Invitation to Participate

RACGP fellows are invited to complete this one-minute online questionnaire, in affiliation with the University of Sydney and Western Sydney Local Health District, assessing clinician perspectives on psoriasis.

Your responses will be informative as to standard practices of care, which is important for establishing a collective approach to the management of these patients. We strongly encourage you to participate.

Your responses are anonymous and will remain strictly confidential. All information collected will be non-identifiable.

The questionnaire closes in 6 weeks. Please submit the survey only once.

Click here to complete the questionnaire.

 

 

PCIG Notes 18 August

Department of Health – Primary Health Care COVID-19 Response Teleconference 18  August 2021 – Meeting notes from Dr Maria Boulton

The Primary Care Implementation Group (PCIG) is an online meeting that includes most primary healthcare peak bodies. It is convened weekly by the Department of Health as part of the COVID-19 response. Dr Maria Boulton attends on behalf of the AGPA. Continue reading “PCIG Notes 18 August”